Cingulate Inc. Information
Contact top employees from
Cingulate Inc.
Summary
Cingulate Inc. is a private company that has been in the industry for 13 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals, Biotechnology areas. The position of the Chairman & CEO is occupied by Shane J. Schaffer. Its headquarters is located at Kansas City, Kansas, USA. The number of employees ranges from 25 to 100. The annual revenue of Cingulate Inc. varies between 5.0M and 25M. Total funding of the company - $33.7M. To connect with Cingulate Inc. employee register on SignalHire.
Organization Website | cingulate.com |
Social Links |  |
Phone Number | 913-942-2300 |
Industries | |
Headquarters Location | 1901 W. 47th Place, Kansas City, Kansas, 66205 US |
Employees Size | 10-50 employees |
SIC Code | 2834, 2836 |
DMA Code | Kansas City Metropolitan Area |
Founded | 2012 |
Estimated Annual Revenue | $5.0M - 25M |
Operating Status | Independent Company |
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2008 | Public Company | 100 - 250 | 57M | $246.5M | |
| 2006 | Public Company | 1 - 25 | 28.4M | $406.2M | |
| 2003 | Public Company | 250 - 500 | 20.7M | $190.2M | |
| 2006 | Public Company | 500 - 1.0K | < 1M | $4.8M |
Estimated Website Traffic
The chart shows a growth in traffic to the cingulate.com website. In November, traffic increased to 14001, compared to 13849 in the previous month. The highest traffic in 2025 was recorded in August, reaching 15972 visits.
Employees Turnover 3 quarter 2025
Length of Employment
Employee tenure at Cingulate Inc. shows a diverse range of experience levels:
6% have been with the company for less than 1 year13% for 1–2 years19% for 3–4 years19% for 5–7 years13% for 8–10 years31% have over 11 years of service at Cingulate Inc.Contact top employees from
Cingulate Inc.
Thomas Dalton
Vice President of Corporate & Government Relations
Bryan Downey
Executive Vice President & Chief Commercial Officer
Naama Courtemanche
Vice President Operations
Craig Tashjy
Vice President of Business Development and Investor Relations
Shane Schaffer
Chairman and CEO
Michael Cattaneo
Vice President Medical Affairs
Daniel Chew
Senior Director Supply Chain
Kelly Koehn
Director of Clinical Operations
Nick Myslinski
Senior Director, Manufacturing Operations & Drug Product Development
Nilay Patel
Chief Legal Officer
Jennifer Callahan
SVP, Chief Financial Officer
Kari Fogleman
Executive Assistant & Office Manager
Laurie Myers
Chief Operating Officer
Jeff Bennett
Deputy General Counsel
Arthur Straughn
Co-Founder
Matthew Brams
Chief Medical Officer
Jennifer Schmitz
Accounting Manager
Bryan Lawrence
Member, Board of Directors
Kelly Kramer
Senior Clinical Trial Manager
Similar Companies
FAQ
Cingulate Inc. operates in the Pharma industries. More details can be found on the official website: cingulate.com.
The headquarters of Cingulate Inc. are located in Kansas City, United States.
The current CEO of Cingulate Inc. is Shane J. Schaffer
You can contact Cingulate Inc. by phone at 913-942-2300.
Cingulate Inc. currently employs 10-50 people.
Cingulate Inc.'s revenue is approximately 5M.
Well-known competitors of Cingulate Inc. include Neos Therapeutics, Inc., Zevra Therapeutics, Zymeworks Inc. and Sirona Biochem Corp..
